Fixed-dose combination tablets of SGLT2 inhibitor, DPP-4 inhibitor, and biguanide for multifaceted type 2 diabetes control. Supplied by multinational pharma firms to bulk buyers like hospital chains and pharmacy benefit managers for streamlined procurement in diabetes care protocols.